Venmax Drugs and Pharmaceuticals Ltd — Important, 12-01-2026: Company Update

Venmax Drugs & Pharmaceuticals Limited has submitted a compliance certificate for the quarter ended December 31, 2025. This certificate, issued by its Registrar and Share Transfer Agent, confirms that all activities related to the dematerialization and rematerialization of shares were processed correctly and within regulatory timelines. This ensures the integrity of the company's share records and proper handling of investor share movements, upholding adherence to market norms.